Providing education, support, advocacy, and promoting research
for CTX patients, their families, and medical professionals
who treat and study this rare disease.
Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies
Zaccai TCF, Hassin-Baer S, Kfir NC, Duell PB, Neerhof M, Sloma R, Roitman M, Kisanuki YY, Verrips A, DeBarber AE. Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies. Genet Med. 2024 May;26(5):101086. doi: 10.1016/j.gim.2024.101086. Epub 2024 Jan 27. PMID: 38288684
Join The CTX Alliance
Join our mailing list to receive information and news as we begin to gather and expand the CTX community.
Support the CTX Alliance
1586 Sumneytown Pike
PO Box 1322
Kulpsville, PA 19443
info@ctxalliance.org
Latest CTX Articles
- Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis March 17, 2025
- Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies March 17, 2025
- Cerebrotendinous Xanthomatosis occurs at high frequency in Ashkenazi Jews March 17, 2025
